本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Quince Therapeutics, Inc.

1.10
-0.0300-2.65%
盘前1.180.0800+7.27%08:00 EDT
成交量:7.85万
成交额:8.71万
市值:4,840.18万
市盈率:-0.84
高:1.18
开:1.13
低:1.07
收:1.13
数据加载中...
2025/03/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2024/12/24

SEC问询函

Form CORRESP - Correspondence
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/13

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals